Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jordan Bio-Industries Center, commonly known as JOVAC, is a private Jordanian biotech and biologics manufacturer focused on veterinary vaccines and biological diagnostic reagents. The company was established in 1986 and later privatized, and it operates from Amman, Jordan. JOVAC develops, manufactures, distributes, and exports vaccines for poultry and farm animals, with products spanning viral and bacterial veterinary diseases. Publicly available materials indicate a portfolio that includes Newcastle disease, infectious bursal disease, infectious bronchitis, sheep pox, goat pox, lumpy skin disease, and brucellosis-related products. The business appears to be a commercial-stage animal health manufacturer rather than a human therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jordan Bio-Industries Center.